首页> 美国卫生研究院文献>Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis >Seventeen Years’ Experience of Peritoneal Dialysis in Iran: First Official Report of the Iranian Peritoneal Dialysis Registry
【2h】

Seventeen Years’ Experience of Peritoneal Dialysis in Iran: First Official Report of the Iranian Peritoneal Dialysis Registry

机译:伊朗十七年腹膜透析的经验:伊朗腹膜透析注册处的首次正式报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

♦ Background: To facilitate planning, national renal registries provide reliable and up-to-date information on numbers of patients with end-stage renal disease (ESRD), developing trends, treatment modalities, and outcomes. To that end, the present publication represents the first official report from Iranian Peritoneal Dialysis Registry.♦ Methods: The prevalence, demographics, and clinical characteristics of patients on peritoneal dialysis (PD) were collected from all PD centers throughout the country.♦ Results: By the end of 2009, the prevalence of ESRD was 507 per million population in Iran. The most common renal replacement modality was hemodialysis (51.2%), followed by kidney transplantation (44.7%), and then PD (4.1%). The mean age of PD patients was 46 years, and the most common causes of ESRD were diabetes (33.5%), hypertension (24.4%), and glomerulonephritis (8.2%). Overall patient mortality was 25%, with cardiac events (46%), cerebral stroke (10%), and infection (8%) being the main causes of death. The 1-, 3-, and 5-year survivals were 89%, 64%, and 49% respectively. The most common cause of dropout was peritonitis (17.6%). Staphylococcus (coagulase-negative and S. aureus) was the most prevalent causative organism in peritonitis episodes; however, in more than 50% of episodes, a sterile culture was reported. Mean baseline serum hemoglobin and albumin were 10.7 g/dL and 3.6 g/dL respectively.♦ Conclusions: Our registry results, representing the second largest report of PD in the Middle East, is almost comparable to available regional data. We hope that, in future, we can improve our shortcomings and lessen the gap with developed countries.
机译:♦背景:为了促进规划,国家肾脏病登记处提供了有关晚期肾病(ESRD)患者人数,发展趋势,治疗方式和结果的可靠且最新的信息。为此,本出版物是伊朗腹膜透析注册处的第一份正式报告。♦方法:从全国所有PD中心收集腹膜透析(PD)患者的患病率,人口统计学和临床​​特征。♦结果:到2009年底,伊朗的ESRD患病率为每百万人口507人。最常见的肾脏替代治疗是血液透析(51.2%),其次是肾脏移植(44.7%),然后是PD(4.1%)。 PD患者的平均年龄为46岁,最常见的ESRD原因是糖尿病(33.5%),高血压(24.4%)和肾小球肾炎(8.2%)。总体患者死亡率为25%,其中心脏事件(46%),脑卒中(10%)和感染(8%)是主要的死亡原因。 1年,3年和5年生存率分别为89%,64%和49%。辍学的最常见原因是腹膜炎(17.6%)。在腹膜炎发作中,葡萄球菌(凝固酶阴性和金黄色葡萄球菌)是最普遍的致病菌。但是,在超过50%的发作中,报告了无菌培养。平均基线血清血红蛋白和白蛋白分别为10.7 g / dL和3.6 g / dL。♦结论:我们的注册结果代表了中东地区PD的第二大报告,几乎与现有的区域数据具有可比性。我们希望,将来,我们可以改善我们的缺点,并减少与发达国家的差距。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号